These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1649953)

  • 21. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
    Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
    Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A.
    Mason AJ; Farnworth PG; Sullivan J
    Mol Endocrinol; 1996 Sep; 10(9):1055-65. PubMed ID: 8885240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of specific inhibin A-binding proteins on mouse Leydig (TM3) and sertoli (TM4) cell lines.
    Harrison CA; Farnworth PG; Chan KL; Stanton PG; Ooi GT; Findlay JK; Robertson DM
    Endocrinology; 2001 Apr; 142(4):1393-402. PubMed ID: 11250918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.
    Welt C; Sidis Y; Keutmann H; Schneyer A
    Exp Biol Med (Maywood); 2002 Oct; 227(9):724-52. PubMed ID: 12324653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
    Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
    Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric cell-kinetic analysis by simultaneously staining nuclei with propidium iodide and fluorescein isothiocyanate.
    Pollack A
    Methods Cell Biol; 1990; 33():315-23. PubMed ID: 1707490
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of type II activin receptors. Binding, processing, and phosphorylation.
    Mathews LS; Vale WW
    J Biol Chem; 1993 Sep; 268(25):19013-8. PubMed ID: 8395525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous fluorescent labeling of DNA, RNA, and protein.
    Crissman HA; Darzynkiewicz Z; Steinkamp JA; Tobey RA
    Methods Cell Biol; 1990; 33():305-14. PubMed ID: 1707489
    [No Abstract]   [Full Text] [Related]  

  • 29. [Family of inhibins and activins: from endocrine to paracrine action].
    Pigny P; Dewailly D; Racadot A; Boersma A
    Ann Endocrinol (Paris); 1996; 57(5):385-94. PubMed ID: 8991102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
    Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
    J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hope, hypothesis, and the inhibin receptor. Does specific inhibin binding suggest there is a specific inhibin receptor?
    Woodruff TK
    Endocrinology; 1999 Jan; 140(1):3-5. PubMed ID: 9886799
    [No Abstract]   [Full Text] [Related]  

  • 32. Localization of inhibin and activin binding sites in the testis during development by in situ ligand binding.
    Krummen LA; Moore A; Woodruff TK; Covello R; Taylor R; Working P; Mather JP
    Biol Reprod; 1994 Apr; 50(4):734-44. PubMed ID: 8199254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present status of research on inhibin: an appraisal.
    Baker HW; Burger HG; de Kretser DM; Findlay JK; Hudson B; Lee VW; Tsonis CG
    Clin Reprod Fertil; 1983 Sep; 2(3):161-74. PubMed ID: 6329502
    [No Abstract]   [Full Text] [Related]  

  • 34. Pituitary binding of 3H-labeled Sertoli cell factor in vitro: a potential radioreceptor assay for inhibin.
    Seethalakshmi L; Steinberger A; Steinberger E
    Endocrinology; 1984 Oct; 115(4):1289-94. PubMed ID: 6090098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells.
    Bilezikjian LM; Blount AL; Campen CA; Gonzalez-Manchon C; Vale W
    Mol Endocrinol; 1991 Oct; 5(10):1389-95. PubMed ID: 1663577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line Tera-2.
    de Jong FH; de Winter JP; Wesseling JG; Timmerman MA; van Genesen S; van den Eijnden-van Raaij AJ; van Zoelen EJ
    Biochem Biophys Res Commun; 1993 May; 192(3):1334-9. PubMed ID: 8389547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia.
    Casagrandi D; Bearfield C; Geary J; Redman CW; Muttukrishna S
    Mol Hum Reprod; 2003 Apr; 9(4):199-203. PubMed ID: 12651901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of in vivo phosphorylation of activin type II receptor.
    Ichijo H; Yamashita H; ten Dijke P; Eto Y; Heldin CH; Miyazono K
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1508-14. PubMed ID: 8394710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression cloning of an activin receptor, a predicted transmembrane serine kinase.
    Mathews LS; Vale WW
    Cell; 1991 Jun; 65(6):973-82. PubMed ID: 1646080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibin, activin and the female reproductive axis.
    Woodruff TK; Mather JP
    Annu Rev Physiol; 1995; 57():219-44. PubMed ID: 7778866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.